(Q39433862)

11 September 2017

title

Microenvironmental regulation of tumour angiogenesis (English)

1 reference

11 September 2017

1 reference

1 reference

1

Michele De Palma

1 reference

11 September 2017

Daniela Biziato

2

1 reference

11 September 2017

Tatiana V Petrova

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

14 July 2017

1 reference

11 September 2017

published in

Nature Reviews Cancer

1 reference

11 September 2017

volume

17

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

457-474

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc.2017.51

11 September 2017

exact match

0 references

cites work

Basic and therapeutic aspects of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The ever-expanding role of HIF in tumour and stromal biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The hypoxic response of tumors is dependent on their microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumors as organs: complex tissues that interface with the entire organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Functional subsets of mesenchymal cell types in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The biology and function of fibroblasts in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Stem cells in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophage regulation of tumor angiogenesis: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The Multifaceted Role of Perivascular Macrophages in Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tie2 Expression on Macrophages Is Required for Blood Vessel Reconstruction and Tumor Relapse after Chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Myeloid-Specific Blockade of Notch Signaling Attenuates Choroidal Neovascularization through Compromised Macrophage Infiltration and Polarization in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophages form functional vascular mimicry channels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Neutrophils in cancer: neutral no more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: key role of Stat3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Mast cells and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Mast cells are an essential hematopoietic component for polyp development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

B cells promote tumor progression via STAT3 regulated-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Platelet secretion is kinetically heterogeneous in an agonist-responsive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Pharmacological regulation of platelet factors that influence tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Platelet granule secretion continuously prevents intratumor hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Platelets actively sequester angiogenesis regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Pericytes limit tumor cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Type-2 pericytes participate in normal and tumoral angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Dynamic interplay between the collagen scaffold and tumor evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Adiposity and cancer risk: new mechanistic insights from epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Fatty acid carbon is essential for dNTP synthesis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor Stroma, Tumor Blood Vessels, and Antiangiogenesis Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Remodelling the extracellular matrix in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Extracellular matrix, inflammation, and the angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The impact of the extracellular matrix on inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Emerging roles of CCN proteins in vascular development and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The regulatory function of SPARC in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

A mechanosensitive transcriptional mechanism that controls angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tissue deformation spatially modulates VEGF signaling and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Metabolic Reprogramming of Immune Cells in Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The Link Between Angiogenesis and Endothelial Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Modulation of oxidative stress as an anticancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Pathological neoangiogenesis depends on oxidative stress regulation by ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, doubl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Extracellular vesicles as new players in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Activated Stat5 trafficking Via Endothelial Cell-derived Extracellular Vesicles Controls IL-3 Pro-angiogenic Paracrine Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Ten years of anti-vascular endothelial growth factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Macrophage regulation of tumor responses to anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

PI3Kγ is a molecular switch that controls immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Active immunotherapy induces antibody responses that target tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Endothelial cell heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor angiogenesis--characteristics of tumor endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Selective blockade of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor-associated endothelial cells with cytogenetic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Oxidative stress in angiogenesis and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Transdifferentiation of glioblastoma cells into vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Vasculogenic mimicry in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

The parallel lives of angiogenesis and immunosuppression: cancer and other tales

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

31 March 2020

Eosinophils and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Therapeutic targeting of the angiopoietin-TIE pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor induction of VEGF promoter activity in stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

CD4+ T Cell Activation and Vascular Normalization: Two Sides of the Same Coin?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2017.51

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor

31 March 2020

1 reference

12 December 2020

Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations

1 reference

12 December 2020

Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.

1 reference

12 December 2020

Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

1 reference

12 December 2020

More than a scaffold: Stromal modulation of tumor immunity.

1 reference

12 December 2020

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma

1 reference

12 December 2020

Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice

1 reference

12 December 2020

Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.

1 reference

12 December 2020

Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts

1 reference

12 December 2020

Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment

1 reference

12 December 2020

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

1 reference

12 December 2020

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma

1 reference

12 December 2020

Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.

1 reference

12 December 2020

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

1 reference

12 December 2020

The role of blood platelets in tumor angiogenesis

1 reference

12 December 2020

Intracellular pool of vascular endothelial growth factor in human neutrophils

1 reference

12 December 2020

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC.2017.51

1 reference

release_ne7vw3bb3fgsjmlfuq2k2vgwvu

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ne7vw3bb3fgsjmlfuq2k2vgwvu

24 November 2022

mapped directly with Wikidata item

1 reference